X842 Placebo

DRUG2 trials

Sponsors

Jiangsu Sinorda Biomedicine Co., Ltd

Conditions

Reflux Esophagitis

Phase 2

Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis

CompletedNCT04531475

Jiangsu Sinorda Biomedicine Co., LtdReflux Esophagitis

Start: 2020-01-21End: 2021-01-12Updated: 2025-07-17

Phase 3

The Phase III Clinical Trial of X842 Capsules for Reflux Esophagitis

CompletedNCT07079540

Jiangsu Sinorda Biomedicine Co., LtdReflux Esophagitis

Start: 2021-06-24End: 2022-12-01Updated: 2025-07-23